Menu

Regulatory

 

Successful partnering in pharmacovigilance for clinical trials

Successful partnering in pharmacovigilance for clinical trials

Gary Barker, Denise Moody, Magda Santos and April Pierce provide insight into creating and keeping a successful pharmacovigilance partnership with a functional service provider.

Read more...
 

Local regulatory affiliates

The future of the local regulatory affiliate: Adjusting to global strategies, processes and expectations

Alistair Davidson, senior director, regulatory affairs, discusses the work of local regulatory affiliates.

Read more...
 

Positive changes in the Latin American clinical trial regulatory environment

Positive changes in the Latin American clinical trial regulatory environment

Andres Bayona, executive director in clinical monitoring and regional head of Latin America, and Mercedes Ponce de Leon, senior manager in regulatory affairs, discuss the clinical trial regulatory landscape in Latin America.

Read more...
 

First-in-health regulatory changes Kirsten Messmer

Seeking ways to ensure participant safety in first-in-human trials

Kirsten Messmer, Ph.D., R.A.C., principal regulatory affairs specialist, details changes in regulatory guidelines for first-in-human trials.

Read more...
 

Brexit’s potential regulatory impact on the pharmaceutical industry

Brexit's potential regulatory impact on the pharmaceutical industry

Regulatory affairs experts at PPD, Alistair Davidson and Vincenzo Cannizzaro, reflect on how the United Kingdom's departure from the European Union might impact the pharmaceutical industry.

Read more...
Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2018 Pharmaceutical Product Development, LLC. All rights reserved.